US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Nov 1, 2023 (3 years ago)

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules

What was recalled

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30

Recalling firm
Padagis US LLC
Origin
MN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0139-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all